 |
|
Top Psychiatry Researchers Honoured with International Career Development Award
May 24, 2005American Psychiatric Association and AstraZeneca Reward '2004 Young Minds in Psychiatry' Winners
The American Psychiatric Association (APA) and AstraZeneca today announced the winners of their prestigious 'Young Minds in Psychiatry' awards programme which aims to recognise excellence and support development amongst young leaders in the field of psychiatry research from around the world. The award presentations took place at the APA's 158th Annual Meeting during the Early Research Career Breakfast meeting, where it was also announced that submissions are now being welcomed for the 2005 awards programme.
The 2004 Awards Programme attracted over 35 submissions from around the world and these were reviewed by a panel of acclaimed psychiatry experts. "The extremely high quality of these entrants is a very positive indicator for the future of mental health research around the world," commented Dr. Darrel A. Regier, Executive Director of the American Psychiatric Institute for Research and Education. "The diversity and insightfulness of the entries made the judging process a particularly difficult task." Submissions were reviewed based on the strength of proposal, the future potential of the candidates, and their career advancement prospects.
Five winners were selected across two research categories; schizophrenia and bipolar disorder. A winner from both the US and the international community were selected in each category for the importance and value of their research proposal, each winning a career development award of $45,000. This year, due to the outstanding level of excellence amongst the entrants, two applicants share the International Bipolar Award.
The 2004 Young Minds in Psychiatry Awards were won by Raymond Y. Cho, USA (schizophrenia), Stefan Leucht, Germany (schizophrenia), Alexander B. Niculescu III, USA (bipolar disorder), Jose M. Goikolea, Spain (bipolar disorder), and Etheldreda Nakimuli-Mpungu, Uganda (bipolar disorder).
Dr. Nakimuli-Mpungu's award will enable her to review bipolar disorder amongst HIV / AIDS patients in Uganda, an important area where little research exists to date. HIV positive patients who also have bipolar disorder but are untreated, may not take their prescribed HIV medication which can cause resistance to the HIV drugs and lead to further complications. Dr. Nakimuli-Mpungu plans to develop a PhD proposal from this study.
Dr. Leucht will review duration of response of antipsychotics in schizophrenia patients, a poorly understood area despite 50 years of effective antipsychotic drug development. Dr. Leuchts' long-term goal is to run his own research institute with a focus on evidence-based medicine in mental health.
Dr. Niculescu's study has the goal of developing and applying a novel approach to better understand the phenotypic structure of psychotic disorders, called PhenoChipping. Commenting on winning the award, Dr. Niculescu noted that "winning the Young Minds in Psychiatry Award provides recognition, impetus and seed money for the more ambitious aspects of my work." His ultimate career goals as an academic psychiatrist and translational researcher are to help understand how the brain works, by integrating genetics with neurobiology, and at a clinical level, to help foster the era of personalized medicine in psychiatry.
Dr. Cho will be investigating how impaired context processing impacts the life of those people living with schizophrenia, which could ultimately aid in the development of early prognostic indicators as well as help improve cognition in this debilitating disorder.
Dr. Goikolea will be investigating the role that fronto-temporal white matter plays in patients with bipolar disorder, and this project will form the basis of his doctoral thesis. "This award will allow me to devote a large proportion of my work to creating a whole research line on neuroimaging in bipolar disorder," commented Dr. Goikolea.
The 2005 'Young Minds in Psychiatry Awards Programme' is also launched today at the APA meeting. Researchers who are within 5 years of completing a psychiatric residency can apply for the award by submitting a proposal of scientific merit that demonstrates academic promise and explaining how winning an award will further their career. "We encourage applications across a broad range of activities, and are extremely proud to be a part of this award programme supporting rising stars in the field of psychiatry. It is important for us to nurture and support those at the front-line of future research and advance in this medical field" comments Jamie Mullen, AstraZeneca.
Application forms can be found via: http://youngminds.astrazeneca.com/
Shire Health International
Five winners were selected across two research categories; schizophrenia and bipolar disorder. A winner from both the US and the international community were selected in each category for the importance and value of their research proposal, each winning a career development award of $45,000. This year, due to the outstanding level of excellence amongst the entrants, two applicants share the International Bipolar Award.
The 2004 Young Minds in Psychiatry Awards were won by Raymond Y. Cho, USA (schizophrenia), Stefan Leucht, Germany (schizophrenia), Alexander B. Niculescu III, USA (bipolar disorder), Jose M. Goikolea, Spain (bipolar disorder), and Etheldreda Nakimuli-Mpungu, Uganda (bipolar disorder).
Dr. Nakimuli-Mpungu's award will enable her to review bipolar disorder amongst HIV / AIDS patients in Uganda, an important area where little research exists to date. HIV positive patients who also have bipolar disorder but are untreated, may not take their prescribed HIV medication which can cause resistance to the HIV drugs and lead to further complications. Dr. Nakimuli-Mpungu plans to develop a PhD proposal from this study.
Dr. Leucht will review duration of response of antipsychotics in schizophrenia patients, a poorly understood area despite 50 years of effective antipsychotic drug development. Dr. Leuchts' long-term goal is to run his own research institute with a focus on evidence-based medicine in mental health.
Dr. Niculescu's study has the goal of developing and applying a novel approach to better understand the phenotypic structure of psychotic disorders, called PhenoChipping. Commenting on winning the award, Dr. Niculescu noted that "winning the Young Minds in Psychiatry Award provides recognition, impetus and seed money for the more ambitious aspects of my work." His ultimate career goals as an academic psychiatrist and translational researcher are to help understand how the brain works, by integrating genetics with neurobiology, and at a clinical level, to help foster the era of personalized medicine in psychiatry.
Dr. Cho will be investigating how impaired context processing impacts the life of those people living with schizophrenia, which could ultimately aid in the development of early prognostic indicators as well as help improve cognition in this debilitating disorder.
Dr. Goikolea will be investigating the role that fronto-temporal white matter plays in patients with bipolar disorder, and this project will form the basis of his doctoral thesis. "This award will allow me to devote a large proportion of my work to creating a whole research line on neuroimaging in bipolar disorder," commented Dr. Goikolea.
The 2005 'Young Minds in Psychiatry Awards Programme' is also launched today at the APA meeting. Researchers who are within 5 years of completing a psychiatric residency can apply for the award by submitting a proposal of scientific merit that demonstrates academic promise and explaining how winning an award will further their career. "We encourage applications across a broad range of activities, and are extremely proud to be a part of this award programme supporting rising stars in the field of psychiatry. It is important for us to nurture and support those at the front-line of future research and advance in this medical field" comments Jamie Mullen, AstraZeneca.
Application forms can be found via: http://youngminds.astrazeneca.com/
Shire Health International
Schizophrenia News and Current Schizophrenia Events RSSSevere, acute maternal stress linked to the development of schizophrenia
Pregnant women who endure the psychological stress of being in a war zone are more likely to give birth to a child who develops schizophrenia.
Unlocking mystery of why dopamine freezes Parkinson's patients
Parkinson's disease and drug addiction are polar opposite diseases, but both depend upon dopamine in the brain. Parkinson's patients don't have enough of it; drug addicts get too much of it. Although the importance of dopamine in these disorders has been well known, the way it works has been a mystery.
Human brains pay a price for being big
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
Estrogen relieves psychotic symptoms in women with schizophrenia
When combined with antipsychotic medications, the estrogen estradiol appears to be a useful treatment in women with schizophrenia, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
N.Y. Research Team Discovers How Antidepressants and Cocaine Interact with Brain Cell Targets
In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction.
Study Shows Promising Results in Deep Brain Stimulation for Treatment-Resistant Depression
New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time.
Protein marker for schizophrenia risk
A protein found in immune cells may be a reliable marker for schizophrenia risk, report researchers in a new proteomics study appearing in the July issue of Molecular and Cellular proteomics.
Schizophrenia linked to dysfunction in molecular brain pathway activated by marijuana
Alterations in a molecular brain pathway activated by marijuana may contribute to the cognitive symptoms of schizophrenia, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Violence declines with medication use in some with schizophrenia
Some schizophrenia patients become less prone to violence when taking medication, but those with a history of childhood conduct problems continue to pose a higher risk even with treatment, according to a new study by researchers at Duke University Medical Center.
NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression
New findings from research supported by NARSAD, the world's leading charity dedicated to mental health research, and conducted by Harvard-affiliated scientists are providing important clues into how genes work to impair various aspects of attention, memory and perception -- the behaviors associated with many psychiatric illnesses, such as schizophrenia, bipolar disorder and depression.
More Schizophrenia News Articles
 | The Soloist: A Lost Dream, an Unlikely Friendship, and the Redemptive Power of Music by Steve Lopez A moving story of the remarkable bond between a journalist in search of a story and a homeless, classically trained musician—destined to be a major motion picture from DreamWorks, starring Jamie Foxx and Robert Downey Jr.When Steve Lopez saw Nathaniel Ayers playing his heart out on a two-string violin on Los Angeles’ skid row, he found it impossible to walk away. More than thirty years earlier,... |
 | Abnormal Psychology (5th Edition) by Thomas F. Oltmanns, Robert E. Emery This new edition retains the book's engaging and innovative systems approach, integrating the biological, psychological, and social perspectives in one concurrent story. Scientific methods are presented in a clear and non-threatening manner, and are based on the most current research. Chapter topics include personality disorders, eating disorders, substance use disorders, sexual and gender... |
 | Center Cannot Hold, The: My Journey Through Madness by Elyn R. Saks Elyn Saks is a success by any measure: she's an endowed professor at the prestigious University of Southern California Gould School of Law. She has managed to achieve this in spite of being diagnosed as schizophrenic and given a "grave" prognosis -- and suffering the effects of her illness throughout her life.Saks was only eight, and living an otherwise idyllic childhood in sunny 1960s Miami,... |
 | The Quiet Room: A Journey Out of the Torment of Madness by Lori Schiller, Amanda Bennett |
 | Mad In America: Bad Science, Bad Medicine, and The Enduring Mistreatment of the Mentally Ill by Robert Whitaker Hot on the heels of an optimistic film about Nobelist John Nash's schizophrenic journey comes medical journalist Robert Whitaker's disturbing exposé of the cruel and corrupt business of treating mental illness in America. Mad in America begins by surveying three centuries of mental health treatments to discover why positive outcomes for schizophrenics in the U.S. for the last 25 years have... |
 | Surviving Schizophrenia: A Manual for Families, Consumers, and Providers (4th Edition) by E. Fuller Torrey The third edition of this indispensable manual thoroughly details everything patients, families, and mental health professionals need to know about one of the most widespread and misunderstood... |
 | A Thousand Plateaus: Capitalism and Schizophrenia by Gilles Deleuze, Felix Guattari, Brian Massumi |
 | Gut and Psychology Syndrome: Natural Treatment for Autism,ADD/ADHD,Dyslexia,Dyspraxia,Depression,Schizophrenia by Dr. Natasha Campbell-McBride MD Book Description Dr. Natasha Campbell-McBride set up The Cambridge Nutrition Clinic in 1998. As a parent of a child diagnosed with learning disabilities, she was acutely aware of the difficulties facing other parents like her, and she has devoted much of her time to helping these families. She realised that nutrition played a critical role in helping children and adults to overcome their... |
 | Nutrition and Mental Illness: An Orthomolecular Approach to Balancing Body Chemistry by Carl C. Pfeiffer Believing that drugs and psychoanalysis were not always the best course of treatment for a variety of mental illnesses, Dr. Carl Pfeiffer began an extensive program of research into the causes and treatment of mental illness, and in 1973 opened the Brain Bio Center in Princeton, New Jersey. Here, with a team of scientists, he found that many psychological problems can be traced to biochemical... |
 | Abnormal Psychology in a Changing World by Jeffrey S. Nevid, Spence A. Rathus, Beverly Greene This introduction to abnormal psychology is designed to make the material more accessible and inviting to a new generation in a changing world. Noteworthy for its clear and engaging writing style that is accessible to readers, superior pedagogy, many engaging case examples and user-oriented applications, and integration of sociocultural material throughout. The authors adopt an interactionist... |
| © 2008 BrightSurf.com |